Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9100
|
pubmed:dateCreated |
1998-3-18
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
351
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
418-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9482302-Ceftriaxone,
pubmed-meshheading:9482302-Cephalosporins,
pubmed-meshheading:9482302-Child,
pubmed-meshheading:9482302-Humans,
pubmed-meshheading:9482302-Lyme Disease,
pubmed-meshheading:9482302-Male,
pubmed-meshheading:9482302-Time Factors,
pubmed-meshheading:9482302-Tourette Syndrome
|
pubmed:year |
1998
|
pubmed:articleTitle |
Lyme disease presenting as Tourette's syndrome.
|
pubmed:publicationType |
Letter,
Case Reports
|